210641-15-9 Usage
Uses
Used in Pharmaceutical Industry:
5-(Hydroxymethyl)-N-methylisoxazole-3-carboxamide is used as a pharmaceutical compound for its potential anti-inflammatory and anti-fungal properties, offering a new avenue for the treatment of various diseases.
Used in Oncology:
In the field of oncology, 5-(Hydroxymethyl)-N-methylisoxazole-3-carboxamide is used as a potential therapeutic agent for cancer treatment, given its pharmacological properties that may contribute to the management and mitigation of cancerous conditions.
Used in Neurodegenerative Disorder Treatment:
5-(Hydroxymethyl)-N-methylisoxazole-3-carboxamide is utilized as a potential treatment for neurodegenerative disorders, leveraging its pharmacological profile to address the complex病理ological mechanisms at play in such conditions.
Used in Drug Formulation Development:
5-(Hydroxymethyl)-N-methylisoxazole-3-carboxamide is employed in the development of new drug formulations, where its unique structure and properties can be harnessed to improve the efficacy, delivery, and safety of medications.
Used in Therapeutic Interventions:
5-(Hydroxymethyl)-N-methylisoxazole-3-carboxamide is used in the design of therapeutic interventions, particularly for conditions that may benefit from its anti-inflammatory and anti-fungal capabilities, as well as its potential to target specific disease pathways.
Check Digit Verification of cas no
The CAS Registry Mumber 210641-15-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,0,6,4 and 1 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 210641-15:
(8*2)+(7*1)+(6*0)+(5*6)+(4*4)+(3*1)+(2*1)+(1*5)=79
79 % 10 = 9
So 210641-15-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O3/c1-7-6(10)5-2-4(3-9)11-8-5/h2,9H,3H2,1H3,(H,7,10)
210641-15-9Relevant articles and documents
Novel E,E-diene compounds and their use as medicaments and cosmetics
-
Paragraph 0135; 0136, (2014/01/07)
The present invention relates to a novel class of E,E-diene compounds and their use as a medicament, preferably as a dermatologic agent, and as a cosmetic. These novel compounds are particularly useful in treating and/or preventing inflammation, irritation, itching, pruritus, pain, oedema and/or pro-allergic or allergic conditions in a patient. Usually they are topically applied to the skin or mucosa in the form of a pharmaceutical or cosmetic composition comprising the compound and a pharmaceutically and/or cosmetically acceptable carrier.
An anomalous hydration/dehydration sequence for the mild generation of a nitrile oxide
Nishiwaki, Nagatoshi,Kobiro, Kazuya,Kiyoto, Hideyuki,Hirao, Shotaro,Sawayama, Jun,Saigo, Kazuhiko,Okajima, Yoshikazu,Uehara, Toshiharu,Maki, Asaka,Ariga, Masahiro
experimental part, p. 2832 - 2839 (2011/05/04)
A nitrile oxide containing a carbamoyl group is readily generated upon the treatment of 2-methyl-4-nitro-3-isoxazolin-5(2H)-one with water under mild reaction conditions, even in the absence of special reagents. The obtained nitrile oxide undergoes cycloa
Improved generation method for functionalized nitrile oxide
Nishiwaki, Nagatoshi,Uehara, Toshiharu,Asaka, Noriko,Tohda, Yasuo,Ariga, Masahiro,Kanemasa, Shuji
, p. 4851 - 4852 (2007/10/03)
Gentle generation of nitrile oxide bearing a carbamoyl group was performed. 4-Nitro-3-isoxazolin-5-one was treated with dipolarophiles in the mixed solvent (MeCN/H2O) at room temperature to afford cycloadducts in good yields.
